BACKGROUND: The human 5-HT (2C) receptor gene has been localized on the X chromosome and is expressed in two genetic variants. Whereas previous investigations have suggested that the 5-HT (2C) receptor gene polymorphism is critically involved in the pathogenesis of affective and eating disorders, as yet the functional consequences being associated with the rare serine variant of the 5-HT (2C) receptor in humans are unclear. METHODS: We explored by HMPAO-SPECT if a challenge with the serotonin agonist mCPP, that interacts mainly with the 5-HT (2C) receptor, provokes different patterns of regional cerebral bloodflow (rCBF) as a function of the genetic variant of the receptor. Thus we studied its action in 16 healthy male volunteers carrying the common 5-HT (2C)-cys-23 receptor gene and 16 healthy male volunteers carrying the less frequent 5-HT (2C)-ser-23 receptor gene. RESULTS: We found significant differences in rCBF between the two genotypes after mCPP infusion compared to placebo: In the cysteine group rCBF was increased in the left medial prefrontal cortex and decreased in the left anterior cingulate and right medio-temporal cortex, whereas the serine group showed an increase of rCBF in the left medio- and superior-temporal cortex and in cerebellum and a reduced rCBF in the right medial prefrontal cortex. In addition, there was a significant disordinal interaction of the genotype factors and challenge with an increase of rCBF in the serine group and a decrease in the cysteine group in the left motor cortex and calcarine cortex. Additionally, a decrease of rCBF in the serine-group and a simultaneous increase in the cysteine group was found in the right anterior and the left posterior cingulate cortex. CONCLUSION: These findings suggest that differences in the 5-HT (2C) receptor gene polymorphism has functional consequences due to a different responsiveness of the expressed 5-HT (2C) receptor variants.
RCT Entities:
BACKGROUND: The human 5-HT (2C) receptor gene has been localized on the X chromosome and is expressed in two genetic variants. Whereas previous investigations have suggested that the 5-HT (2C) receptor gene polymorphism is critically involved in the pathogenesis of affective and eating disorders, as yet the functional consequences being associated with the rare serine variant of the 5-HT (2C) receptor in humans are unclear. METHODS: We explored by HMPAO-SPECT if a challenge with the serotonin agonist mCPP, that interacts mainly with the 5-HT (2C) receptor, provokes different patterns of regional cerebral bloodflow (rCBF) as a function of the genetic variant of the receptor. Thus we studied its action in 16 healthy male volunteers carrying the common 5-HT (2C)-cys-23 receptor gene and 16 healthy male volunteers carrying the less frequent 5-HT (2C)-ser-23 receptor gene. RESULTS: We found significant differences in rCBF between the two genotypes after mCPP infusion compared to placebo: In the cysteine group rCBF was increased in the left medial prefrontal cortex and decreased in the left anterior cingulate and right medio-temporal cortex, whereas the serine group showed an increase of rCBF in the left medio- and superior-temporal cortex and in cerebellum and a reduced rCBF in the right medial prefrontal cortex. In addition, there was a significant disordinal interaction of the genotype factors and challenge with an increase of rCBF in the serine group and a decrease in the cysteine group in the left motor cortex and calcarine cortex. Additionally, a decrease of rCBF in the serine-group and a simultaneous increase in the cysteine group was found in the right anterior and the left posterior cingulate cortex. CONCLUSION: These findings suggest that differences in the 5-HT (2C) receptor gene polymorphism has functional consequences due to a different responsiveness of the expressed 5-HT (2C) receptor variants.
Authors: Beverly H Brummett; Cynthia M Kuhn; Stephen H Boyle; Michael A Babyak; Ilene C Siegler; Redford B Williams Journal: Biol Psychol Date: 2011-10-01 Impact factor: 3.251
Authors: Brian J Mickey; Benjamin J Sanford; Tiffany M Love; Pei-Hong Shen; Colin A Hodgkinson; Christian S Stohler; David Goldman; Jon-Kar Zubieta Journal: J Neurosci Date: 2012-07-04 Impact factor: 6.167
Authors: Vasileios Boulougouris; Ioannis Malogiannis; George Lockwood; Iannis Zervas; Giuseppe Di Giovanni Journal: Exp Brain Res Date: 2013-08-23 Impact factor: 1.972
Authors: Beverly H Brummett; Michael A Babyak; Rong Jiang; Svati H Shah; Richard C Becker; Carol Haynes; Megan Chryst-Ladd; Damian M Craig; Elizabeth R Hauser; Ilene C Siegler; Cynthia M Kuhn; Abanish Singh; Redford B Williams Journal: PLoS One Date: 2013-12-18 Impact factor: 3.240
Authors: N C Anastasio; S Liu; L Maili; S E Swinford; S D Lane; R G Fox; S C Hamon; D A Nielsen; K A Cunningham; F G Moeller Journal: Transl Psychiatry Date: 2014-03-11 Impact factor: 6.222
Authors: Michelle A Land; Holly L Chapman; Brionna D Davis-Reyes; Daniel E Felsing; John A Allen; F Gerard Moeller; Lisa A Elferink; Kathryn A Cunningham; Noelle C Anastasio Journal: Sci Rep Date: 2019-11-13 Impact factor: 4.379